Breaking News Instant updates and real-time market news.

TLRY

Tilray

$83.10

11.28 (15.71%)

06:10
01/09/19
01/09
06:10
01/09/19
06:10

Tilray initiated with an Overweight at Piper Jaffray

Piper Jaffray analyst Michael Lavery initiated coverage of Tilray with an Overweight rating and $90 price target. The analyst expects "strong" industry growth long-term, and believes Tilray is well positioned to be one of several likely winners given its relationships in medical, in the U.S., and in beverages. Lavery consider the company's initial public offering lock-up expiry to be a near-term risk, especially with 77% insider ownership, but his 12-month Overweight view is based on its fundamental outlook. He pegs Tilray's market opportunity at $15B-$50B in the near-term, and potentially $250B-$500B over the longer term.

  • 14

    Jan

TLRY Tilray
$83.10

11.28 (15.71%)

11/06/18
COWN
11/06/18
NO CHANGE
COWN
Demand for adult use cannabis 'seemingly strong' in Canada, says Cowen
Citing her analysis of e-commerce platforms for adult use cannabis in Canada, Cowen analyst Vivien Azer remains encouraged to see "seemingly strong demand" as well as some instances of improved supply. In a research note pre-market open, the analyst notes she aggregated 533 product offerings with 1,149 SKUs from the e-commerce platforms for Alberta, British Columbia, Ontario, New Brunswick, and Newfoundland and Labrador. Overall, SKU stockout rates across the provinces were flat versus last week at 57%, although remains above the 46% rate during the prior week, Azer adds. Her view of the data is a modest positive for Canopy Growth (CGC), which has the second highest number of SKUs and out of stock rates declined from 65% to 54% while adding 16 SKUs this week. The read-through on Tilray (TLRY) is less clear, Azer contends, as the only three provinces where the company did not get supply agreements were all in her five province survey universe. The analyst reiterated an Outperform rating on Canopy Growth and Tilray.
11/07/18
ADAM
11/07/18
NO CHANGE
ADAM
Midterms broadly positive for U.S. cannabis industry, says Canaccord
Canaccord analyst Bobby Burleson says that as expected, yesterday's midterms delivered several wins for the U.S. cannabis industry, including the passage of three state ballot measures on legalization, key gubernatorial victories by pro-cannabis candidates, and the retaking of the House by Democrats. The analyst views these results as broadly positive for the U.S. cannabis industry. Publicly traded companies in the space include Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC) and Tilray (TLRY).
11/14/18
BNCH
11/14/18
NO CHANGE
Target $200
BNCH
Buy
Tilray reported 'strong' Q3 sales without recreational cannabis, says Benchmark
Benchmark analyst Mike Hickey said Tilray reported "strong" Q3 sales even though the company did not recognize sales from recreational cannabis use in the quarter. Recreational use experienced a slow start, primarily due to the timing of licenses, distribution and retail infrastructure, as expected, said Hickey, who adds that there "appears to be exceedingly strong demand" from Canadians. He has raised his Q4 sales forecast based on increased production and presumed ongoing strong consumer demand and keeps a Buy rating on Tilray with a $200 price target.
12/18/18
COWN
12/18/18
NO CHANGE
COWN
Outperform
Cowen sees Sandoz deal as reinforcing Tilray's competitive positioning
Tilray's (TLRY) expanded global partnership with Novartis (NVS) division Sandoz can not only help expand its reach with pharmacists, physicians and distributors, it can also help Tilray capture early share in new medical cannabis markets as they come online, Cowen analyst Vivien Azer tells investors in a research note. Further, the analyst believes the partnership also helps legitimize cannabis in international markets, which could help influence countries considering medical cannabis legalization. Azer estimates international will represent 15% of Tilray's revenue in fiscal 2020 and 22% in fiscal 2021. Not only does the deal allow Tilray to expand geographic reach, but also to grow at scale, says Azer. And most notably, the Sandoz deal reinforces Tilray's competitive positioning, adds the analyst, who keeps an Outperform rating on the shares with a $150 price target. The stock in morning trading is up 9%, or $5.98, to $71.87.

TODAY'S FREE FLY STORIES

WAB

Wabtec

$73.59

-1.425 (-1.90%)

, GT

Goodyear Tire

$19.19

-0.2 (-1.03%)

17:19
02/21/19
02/21
17:19
02/21/19
17:19
Hot Stocks
Wabtec to replace Goodyear Tire in S&P 500 at open on 2/27 »

General Electric (GE) is…

WAB

Wabtec

$73.59

-1.425 (-1.90%)

GT

Goodyear Tire

$19.19

-0.2 (-1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

BEAT

BioTelemetry

$73.39

-1.98 (-2.63%)

17:19
02/21/19
02/21
17:19
02/21/19
17:19
Earnings
BioTelemetry reports Q4 EPS 56c, consensus 43c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

NKTR

Nektar

$40.26

-2.76 (-6.42%)

17:18
02/21/19
02/21
17:18
02/21/19
17:18
Initiation
Nektar initiated  »

Nektar initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CONE

CyrusOne

$52.44

-4.75 (-8.31%)

17:16
02/21/19
02/21
17:16
02/21/19
17:16
Recommendations
CyrusOne analyst commentary  »

CyrusOne price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 11

    Mar

  • 11

    Mar

  • 18

    Jun

PLD

Prologis

$71.03

0.77 (1.10%)

17:16
02/21/19
02/21
17:16
02/21/19
17:16
Hot Stocks
Prologis raises quarterly dividend 10% to 53c per share »

Payable on March 29 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOK

MyoKardia

$43.19

-0.43 (-0.99%)

17:14
02/21/19
02/21
17:14
02/21/19
17:14
Initiation
MyoKardia initiated  »

MyoKardia initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPM

Wheaton Precious Metals

$21.75

-0.26 (-1.18%)

17:14
02/21/19
02/21
17:14
02/21/19
17:14
Hot Stocks
Wheaton Precious Metals produced 373,239 ounces of gold in 2018 »

Above forecast of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

ENPH

Enphase Energy

$7.37

0.13 (1.80%)

17:13
02/21/19
02/21
17:13
02/21/19
17:13
Hot Stocks
Park West Asset Management reports 5.4% passive stake in Enphase Energy »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

WPM

Wheaton Precious Metals

$21.75

-0.26 (-1.18%)

17:12
02/21/19
02/21
17:12
02/21/19
17:12
Hot Stocks
Wheaton Precious Metals sees 365,000 ounces of gold produced in 2019 »

Wheaton's estimated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

KHC

Kraft Heinz

$48.19

-0.05 (-0.10%)

17:10
02/21/19
02/21
17:10
02/21/19
17:10
Hot Stocks
Kraft Heinz says SEC probing procurement accounting policies »

The company said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ACAM

Acamar Partners

$0.00

(0.00%)

17:10
02/21/19
02/21
17:10
02/21/19
17:10
Syndicate
Acamar Partners 30M share IPO priced at $10.00 »

Goldman Sachs and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMH

American Homes 4 Rent

$22.79

0.11 (0.49%)

17:07
02/21/19
02/21
17:07
02/21/19
17:07
Earnings
Breaking Earnings news story on American Homes 4 Rent »

American Homes 4 Rent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

AMH

American Homes 4 Rent

$22.79

0.11 (0.49%)

17:06
02/21/19
02/21
17:06
02/21/19
17:06
Earnings
American Homes 4 Rent reports Q4 AFFO 25c, consensus 28c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

LPLA

LPL Financial

$76.68

-0.87 (-1.12%)

17:06
02/21/19
02/21
17:06
02/21/19
17:06
Hot Stocks
LPL Financial reports total brokerage, advisory assets at January-end up 5.2% »

Total brokerage and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

OMF

OneMain Holdings

$34.09

-0.45 (-1.30%)

17:05
02/21/19
02/21
17:05
02/21/19
17:05
Initiation
OneMain Holdings initiated  »

OneMain Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 14

    Mar

KHC

Kraft Heinz

$48.19

-0.05 (-0.10%)

17:04
02/21/19
02/21
17:04
02/21/19
17:04
Hot Stocks
Breaking Hot Stocks news story on Kraft Heinz »

Kraft Heinz slips 8.8%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

EVRG

Evergy

$59.86

0.45 (0.76%)

17:02
02/21/19
02/21
17:02
02/21/19
17:02
Earnings
Breaking Earnings news story on Evergy »

Evergy reports Q4 pro…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

KHC

Kraft Heinz

$48.19

-0.05 (-0.10%)

17:02
02/21/19
02/21
17:02
02/21/19
17:02
Earnings
Kraft Heinz reports Q4 adjusted EPS 84c, consensus 94c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

GNMK

GenMark

$6.82

0.11 (1.64%)

17:02
02/21/19
02/21
17:02
02/21/19
17:02
Hot Stocks
GenMark promotes Johnny Ek to CFO »

GenMark Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 06

    Mar

MFIN

Medallion Financial

$5.96

0.14 (2.41%)

17:01
02/21/19
02/21
17:01
02/21/19
17:01
Initiation
Medallion Financial initiated  »

Medallion Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

OTTW

Ottawa Bancorp

$13.55

(0.00%)

17:00
02/21/19
02/21
17:00
02/21/19
17:00
Hot Stocks
Ottawa Bancorp raises quarterly dividend to 6c per share from 5c »

Ottawa Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RM

Regional Management

$27.25

-0.46 (-1.66%)

17:00
02/21/19
02/21
17:00
02/21/19
17:00
Initiation
Regional Management initiated  »

Regional Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ED

Consolidated Edison

$80.00

1 (1.27%)

16:59
02/21/19
02/21
16:59
02/21/19
16:59
Earnings
Breaking Earnings news story on Consolidated Edison »

Consolidated Edison sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

ED

Consolidated Edison

$80.00

1 (1.27%)

16:59
02/21/19
02/21
16:59
02/21/19
16:59
Earnings
Consolidated Edison reports Q4 EPS 77c, consensus 75c »

"We had a strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

OPNT

Opiant Pharmaceuticals

$14.65

-0.25 (-1.68%)

16:57
02/21/19
02/21
16:57
02/21/19
16:57
Hot Stocks
Breaking Hot Stocks news story on Opiant Pharmaceuticals »

Opiant down 11.3% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.